Avadel to Present at H.C. Wainwright 22nd Annual Global

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
86
Avadel to Present at H.C. Wainwright 22nd Annual Global Investment Conference

DUBLIN, Ireland, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the H.C. Wainwright 22 nd Annual Global Investment Conference taking place September 14 – 16, 2020.

Presentation details:
Date:     Wednesday, September 16, 2020
Time:   10:30 a.m. – 10:50 a.m. ET
Webcast:   A live and archived webcast of the presentation will be available at ( click here ) or on the Company’s website ( click here )
     

In addition, management will be participating in one-on-one meetings with investors who are registered to attend the conference.

About Avadel Pharmaceuticals plc: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and potential FDA approval of FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy. For more information, please visit  www.avadel.com .

About FT218 FT218 is an investigational, once-nightly formulation of Micropump™ controlled-release (CR) sodium oxybate. The Company recently completed the REST-ON study, a pivotal, double-blind, randomized, placebo-controlled Phase 3 trial, to assess the efficacy and safety of FT218 in the treatment of excessive daytime sleepiness and cataplexy in patients suffering from narcolepsy. FT218 has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy. The designation was granted on the plausible hypothesis that FT218 may be clinically superior to the twice-nightly formulation of sodium oxybate already approved by the FDA for the same indication. In particular, FT218 may be safer due to ramifications associated with the dosing regimen of the previously approved product.

Contacts:

Investor Contacts Tom McHugh Chief Financial Officer Phone: (636) 449-1843 Email: tmchugh@avadel.com Tim McCarthy LifeSci Advisors, LLC Phone: (212) 915-2564 Email: tim@lifesciadvisors.com Media Contact Patrick Bursey LifeSci Communications, LLC Phone: (646) 970-4688 Email: pbursey@lifescicomms.com
 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rockford Fosgate Elevates Marketing Maverick to Lead Role

Updated Category News Views 87

Changing the Guard in High-Performance Audio Marketing Out of Arizona, we get a shake-up that feels like a no-brainer for anyone in the high-performance audio market. Rockford Fosgate decided to elevate Tammy Lowe to the Vice President of Marketing role, effective immediately. With nearly four decades under her belt at the sunny Tempe-based HQ, it's hard to argue with the...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 30

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading
Anguilla: Paradise for Safe, Solo Beach Escapes

Updated Category News Views 31

A Safe Haven for Solo Adventurers You ever dream of escaping to a place where the world slows down and serenity reigns supreme? Somewhere you can kick back, soak up the sun, listen to the waves, and leave your worries behind? Well, folks, Tranquility Beach Anguilla fits that bill and then some. Why Anguilla Tops the List Let's talk about the accolades Anguilla has raked...

Continue Reading
FuelCell Energy Faces Legal Scrutiny After Stock Plunge

Updated Category News Views 75

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Continue Reading
Food Emulsifiers Surge: Market to Hit $5.60B by 2031

Updated Category News Views 72

Forecasting Growth in Food Emulsifiers Picture this: the food emulsifiers market is steaming ahead, anticipating a thunderous boom from $4.43 billion in 2026 to a whopping $5.60 billion by 2031. According to recent estimates, that's a steady clip at a CAGR of 4.8%. If you're thinking that's just more industry chatter, let's peel back the layers and see what makes this...

Continue Reading
SOTERIA Launches Cancer Hunt™ for Military Patients

Updated Category News Views 66

Breaking the Barriers for Our Military's Cancer Fight Diving into the world of precision medicine, SOTERIA Precision Medicine Foundation has sparked a revolution with Cancer Hunt™. It's staggering to think about the piles of bureaucracy and insurance red tape that often stand between cancer patients and life-saving care. Especially when those patients are veterans or...

Continue Reading
Entangled 2026 Summit: Driving Quantum, AI, & Biotech Synergy

Updated Category News Views 119

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Continue Reading
Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

Updated Category News Views 0

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

Continue Reading
Triskell's 2026 Update: AI Leverages Portfolio Data

Updated Category News Views 33

Triskell's Strategic AI Leap Forward Forget the old grind of manual data tinkering—Triskell Software's latest AI enhancements in their 2026 SP2 release are setting a new stage. The Spain-based outfit is tweaking their Project Portfolio Management tools under the hood to suit modern instincts. It seems like portfolio management is getting a brain boost with some added AI...

Continue Reading
Skechers Faces Shareholder Lawsuit: Must Act by Dec 21

Updated Category News Views 45

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

Continue Reading

Top 5 Most Recently Viewed Articles

Ionpath Introduces MIBIslide™ Blue for Enhanced Imaging

Updated Category News Views 174

Innovative Advances in Multi-Omics Imaging Ionpath, a leading name in high-definition spatial proteomics, has recently launched its newest product, the MIBIslide™ Blue. This groundbreaking technology marks a significant advancement in multimodal imaging, tailored for researchers looking to enhance their imaging capabilities in spatial biology. The MIBIslide Blue...

Continue Reading
Win $1,500 for a Transformative First-Class Flight Experience

Updated Category News Views 129

Transform Your Travel with Upgraded Points' Contest Upgraded Points presents an exciting opportunity for travelers to experience the luxury of first-class flying without the usual financial burden. With the newly launched contest, one lucky winner will be awarded $1,500 to upgrade their domestic round-trip flight to first class and share their journey. This contest is...

Continue Reading
Invesque Inc.'s Q2 2025 Performance Reveals Strategic Changes

Updated Category News Views 96

Significant Progress in Asset Management Invesque Inc. (TSX: IVQ) recently shared promising results for the second quarter of 2025, showcasing significant achievements in asset management and strategic operations. Quarterly Highlights and Operations During this quarter, the company successfully executed several important asset sales: In April, Invesque concluded the sale...

Continue Reading
Goldman Sachs Confirms Buy Rating for CoStar Group's Growth Potential

Updated Category News Views 87

Goldman Sachs Supports CoStar Group with Buy Rating Goldman Sachs has reaffirmed its Buy rating for CoStar Group (NASDAQ: CSGP) and set a price target of $93.00. Recent analyses indicate that online traffic for CoStar's residential platform, Homes.com, has remained consistent, boosting growth expectations. In August, Homes.com attracted 35 million unique visitors, showing...

Continue Reading
LightPath Technologies Enhances Defense Capabilities with New LOI

Updated Category News Views 63

Strengthening Defense Partnerships in Optics LightPath Technologies, Inc. announces an exciting development in its commitment to enhancing optical systems for defense applications. The company has secured a Letter of Intent (LOI) for the sustained supply of infrared lens assemblies from an established European defense customer. This partnership not only represents a...

Continue Reading